• SENSEX 74,781.76
    -120.83 (--0.16%)
  • BANKNIFTY 56,471.95
    176.40 (+0.31%)
  • Molbio Diagnosti
    1,393.10 925.80(%)
  • Pine Labs
    206.10 283.70(%)
  • Larsen & Toubro
    3,880.55 3,288.65(%)
  • HDFC Bank
    708.90 1,020.35(%)
  • Power Grid Corpn
    268.30 250.05(%)
  • ESDS Software
    1,716.35 1,560.35(%)
  • Trent
    2,815.00 3,507.32(%)
  • Raymond
    1,024.00 869.05(%)
  • Metro Brands
    924.20 883.40(%)
  • Reliance Industries
    1,253.20 1,250.55(%)
  • Billionbrains
    200.90 227.00(%)
  • Ather Energy
    1,615.00 521.75(%)
  • One 97
    1,829.50 1,759.05(%)
  • Hind.Aeronautics
    4,861.65 3,479.20(%)
  • UPL
    567.25 558.00(%)
  • HDFC Life Insur.
    531.15 796.60(%)
  • Bajaj Finance
    1,015.40 788.40(%)
  • Lodha Developers
    1,076.00 650.85(%)
  • Dhoot Transmission
    1,727.35 1,673.50(%)
  • Britannia Inds.
    4,946.05 5,000.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Shilpa Medicare Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 5031.0
  • ISIN : INE790G01031
939.90 -21 (-2.15%)
  • As on 11 Sep 2026 (EOD)

  • Today’s Low

    931.30

  • Today’s High

    974.00

  • Open

    968.95

  • Perv Close

    960.60

  • 52W Low

    259.50

  • 52W High

    980.10

Key Indicators

  • P/E(TTM)

    117.38

  • Mar.Cap (₹Cr.)

    18,382.74

  • Div & Yield %

    0.06

  • Book Value(₹)

    138.73

  • Debt-Equity Ratio

    -2.15

  • AGM Date

    10-Sep-2026

  • EPS

    8.01

  • P/E Ratio

    117.38

Financials Ratios

  • Debt-Equity Ratio

    0.48

  • Mar.Cap (₹Cr.)

    18,382.74

  • RONW (%)

    1.72

  • ROCE (%)

    5.16

Score Board

  • Equity (₹ in Cr.)

    19.56

  • BV (₹)

    138.70

  • Sales( ₹ in Cr.)

    597.03

  • NP (in Cr.)

    103.91

  • NP Var(%)

    12.0

  • Div%

    60.0

  • CPS (₹)

    8.10

  • EPS (₹)

    5.30

  • Traded Value (₹ in Lakhs)

    18,389.58

  • 52 Week High

    980.10

  • 52 Week Low

    259.50

  • Price BSE

    940.0

  • Price NSE

    940.00

  • Market Capital( in Cr.)

    18,389.58

  • P/C Ratio

    115.60

  • P/E Ratio

    176.90

  • Price Vs.BV

    5.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 597.03 477.40 309.79 247.70 356.95 257.05
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 597.03 477.40 309.79 247.70 356.95 257.05
Other Income 68.74 70.69 89.12 175.32 170.50 204.49
Stock Adjustments 3.64 -6.00 -2.63 -4.08 3.18 10.26
Total Income 669.41 542.09 396.28 418.94 530.63 471.80
EXPENDITURE :            
Raw Materials 228.10 114.51 86.62 78.12 81.96 69.37
Power and Fuel Cost 18.93 17.89 18.73 18.70 17.47 12.42
Employee Cost 110.99 89.95 103.64 109.54 110.57 76.10
Other Manufacturing Expenses 21.42 12.60 15.32 18.28 22.79 16.71
Selling and Administration Expenses 94.28 99.22 49.74 60.03 106.22 55.92
Miscellaneous Expenses -17.59 47.86 17.26 18.50 -0.57 3.43
Employee Benefit Expenses 110.99 89.95 103.64 109.54 110.57 76.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 456.13 382.03 291.31 303.17 338.44 233.95
Operating Profit 213.28 160.06 104.96 115.78 192.18 237.86
Interest 10.04 5.87 17.26 20.83 9.05 6.07
Gross Profit 203.24 154.19 87.70 94.95 183.13 231.79
Depreciation 55.11 48.86 49.61 46.55 34.82 22.28
Profit Before Tax 148.13 105.33 38.09 48.40 148.31 209.51
Current Tax 10.97 47.08 11.29 -8.37 4.80 15.78
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.18 -9.65 -0.13 -0.43 2.53 9.34
Reported Net Profit 132.98 67.90 26.94 57.19 140.99 184.39
Extraordinary Items 29.07 -24.67 -6.93 -15.86 8.23 46.40
Adjusted Net Profit 103.91 92.57 33.87 73.05 132.76 137.99
Adjustment below Net Profit -56.95 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 1,375.17 1,307.27 1,332.11 1,284.46 1,152.44 968.05
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 9.78 0.00 0.00 9.55 8.97 0.00
P & L Balance carried down 1,441.42 1,375.17 1,359.05 1,332.11 1,284.46 1,152.44
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 60.00 100.00 0.00 0.00 110.00 110.00
Dividend Per Share(Rs) 0.60 1.00 0.00 0.00 1.10 1.10
Earnings Per Share-Unit Curr 6.80 6.94 3.10 6.59 16.24 22.62
Earnings Per Share(Adj)-Unit Curr 6.80 3.47 1.55 3.30 8.12 11.31
Book Value 138.72 270.65 246.85 243.96 237.97 200.89
Book Value(Adj)-Unit Curr 138.72 135.33 123.43 121.99 118.99 100.45

Shareholding Pattern

  • Promoter Group

    40.13%

  • Public Share Holding

    59.87%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 78,496,648 40.13 78,496,648 21
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 78,496,648 40.13 78,496,648 21
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,004 0.00 1,004 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 10 0.00 10 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 22,262,432 11.38 22,262,432 108
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,527,562 2.31 4,527,562 1
Mutual Funds / UTI 8,237,418 4.21 8,237,418 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,984,817 1.53 2,984,817 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 38,013,243 19.44 38,013,243 132
2] Non Institution
Bodies Corporate 17,183,098 8.79 17,183,098 881
Clearing Members 100,544 0.05 100,544 3
Directors of their Relatives 62,150 0.03 62,150 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 5,223,435 2.67 5,223,435 1,565
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,790,133 0.92 1,790,133 1,492
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 21,960,636 11.23 21,960,636 25
Individuals holding nominal share capital up to Rs. 1 lakh 32,162,127 16.44 32,052,377 56,799
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 68,128 0.03 68,128 4
Others 521,674 0.27 521,674 2
Sub Total 79,071,925 40.43 78,962,175 60,773
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 195,581,816 100.00 195,472,066 60,926

Company Background

Shilpa Medicare LtdPharmaceuticals - Indian - Formulations

  • Shilpa Medicare Ltd
  • BSE Code : 5031.0
  • ISIN : INE790G01031

  • Incorporation Year

    1987

  • Registered Office

    #12-6-214/A1
    Hyderabad Road, Raichur,
    Karnataka-584135

  • Telephone

    91-8532-238704

  • FAX

    91-8532238876

  • Chairman

    Omprakash Inani

  • Managing Director

  • Company Secretary

    Ritu Tiwary

  • Auditor

    B N P S and Associates LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Shilpa Medicare Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Shilpa Medicare 940.25 635.18 597.03 100.67 4.78
Abbott India 25,272.60 7,217.19 6,929.05 33.26 43.78
Astrazeneca Phar 6,858.65 2,304.07 2,275.58 101.09 27.86
Glaxosmi. Pharma 2,840.80 3,932.76 3,790.20 45.38 58.17
Novartis India 2,425.05 393.10 354.33 61.24 15.94
Cipla 1,380.00 20,102.60 18,979.95 36.27 13.88
Bliss GVS Pharma 703.70 773.53 729.81 65.40 12.51
Amrutanjan Healt 493.80 520.13 502.55 26.45 24.16
Fermenta Biotec. 483.30 474.15 450.25 22.56 18.77
Guj. Themis Bio. 430.80 168.25 165.82 115.19 18.05
Ambalal Sarabhai 41.45 19.52 3.94 76.76 6.77